We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$653M
AUM Growth
-$26.6M
Cap. Flow
-$25.6M
Cap. Flow %
-3.91%
Top 10 Hldgs %
28.85%
Holding
103
New
1
Increased
52
Reduced
32
Closed
5

Sector Composition

Rank Sector Weight
1 Financials 20.28%
2 Technology 19.31%
3 Healthcare 14.81%
4 Industrials 11.71%
5 Communication Services 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
76
McDonald's
MCD
$192B
$1.78M 0.27%
7,370
+124
+2% +$29.6K
CCI icon
77
Crown Castle
CCI
$32.1B
$1.76M 0.27%
10,140
+158
+2% +$30.5K
ANSS
78
DELISTED
Ansys
ANSS
$1.75M 0.27%
5,134
-281
-5% -$102K
QLYS icon
79
Qualys
QLYS
$6.3B
$1.74M 0.27%
15,633
-1,948
-11% -$213K
SPNS
80
DELISTED
Sapiens International
SPNS
$1.7M 0.26%
59,009
+422
+0.7% +$11.5K
MYOV
81
DELISTED
Myovant Sciences Ltd.
MYOV
$1.67M 0.26%
74,305
+601
+0.8% +$13.2K
HXL icon
82
Hexcel
HXL
$7.1B
$1.66M 0.25%
27,870
+200
+0.7% +$11.5K
BPMC
83
DELISTED
Blueprint Medicines
BPMC
$1.64M 0.25%
15,938
+4,089
+35% +$381K
CSCO icon
84
Cisco
CSCO
$438B
$1.64M 0.25%
30,102
+433
+1% +$24.3K
ICFI icon
85
ICF International
ICFI
$1.6B
$1.54M 0.24%
17,271
+149
+0.9% +$13.5K
TDOC icon
86
Teladoc Health
TDOC
$1.16B
$1.52M 0.23%
11,981
+130
+1% +$18.9K
MKSI icon
87
MKS Inc
MKSI
$18.9B
$1.45M 0.22%
9,637
+118
+1% +$18.1K
DT icon
88
Dynatrace
DT
$14.2B
$1.42M 0.22%
19,986
+2,080
+12% +$136K
BMRN icon
89
BioMarin Pharmaceuticals
BMRN
$12.9B
$1.27M 0.19%
16,403
+204
+1% +$16.1K
CHD icon
90
Church & Dwight Co
CHD
$23.4B
$1.17M 0.18%
14,218
+182
+1% +$15.4K
RCKT icon
91
Rocket Pharmaceuticals
RCKT
$385M
$1.13M 0.17%
37,782
+422
+1% +$15.4K
IPGP icon
92
IPG Photonics
IPGP
$3.12B
$1.04M 0.16%
6,571
+99
+2% +$18.2K
GOOG icon
93
Alphabet (Google) Class C
GOOG
$4.18T
$949K 0.15%
7,120
-20
-0.3% -$2.76K
IWF icon
94
iShares Russell 1000 Growth ETF
IWF
$125B
$551K 0.08%
8,044
-1,800
-18% -$127K
SBUX icon
95
Starbucks
SBUX
$122B
$451K 0.07%
4,085
ECL icon
96
Ecolab
ECL
$78.9B
$286K 0.04%
1,370
IWP icon
97
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
-2,044
Closed -$231K
ORCL icon
98
Oracle
ORCL
$422B
-155,247
Closed -$12.1M
PRAA icon
99
PRA Group
PRAA
$737M
-34,554
Closed -$1.33M
SEIC icon
100
SEI Investments
SEIC
$13.1B
-224,440
Closed -$13.9M

Similar funds

Robert Torray's Q3 2021 Portfolio in Review

As of Q3 2021, Robert Torray held 103 positions worth $653M, down 3.9% from $680M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Robert Torray withdrew a net $25.6M in Q3 2021, closing 5 positions and reducing 32 holdings. Its most notable exit was Royal Dutch Shell PLC ADS Class A, an estimated $15.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Robert Torray opened a new position in EOG Resources worth $10.1M.

  • Robert Torray's largest Q3 2021 buy was EOG Resources: 125,241 shares worth $10.1M.
  • Robert Torray added most to Phillips 66 in Q3 2021, an estimated $8.61M increase.
  • Robert Torray's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $3.91M.
  • Robert Torray fully exited Royal Dutch Shell PLC ADS Class A in Q3 2021, selling an estimated $15.7M.
  • Robert Torray's ten largest holdings make up 29% of its $653M portfolio in Q3 2021.
  • Robert Torray opened 1 new position and closed 5 in Q3 2021.
  • Robert Torray's portfolio value fell 3.9% quarter-over-quarter to $653M.

Based on Torray Investment Partners's 13F filing for Q3 2021, filed 2 Nov 2021.